Inventor · disambiguated record
Jean-Francois Haeuw
Also filed as: HAEUW JEAN-FRANCOIS · HAEUW JEAN-FRANÇOIS
20 granted patents·11 pending applications·157 citations·filing 1995–2024
94Inventor score
Top patents by PatentIndex Score
31 records- 0193US7241444B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2003·Granted Jul 10, 2007·95 cites·17 claims
- 0289US7914784B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2007·Granted Mar 29, 2011·10 cites·19 claims
- 0388US10633448B2IGF-1R antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Apr 28, 2020·4 cites·21 claims
- 0488US8071730B2Anti-JAM-A antibodiesGOETSCH LILIANE·Filed 2008·Granted Dec 6, 2011·7 cites·21 claims
- 0585US10858423B2Composition for the treatment of IGF-1R expressing cancerPF MEDICAMENT·Filed 2016·Granted Dec 8, 2020·3 cites·14 claims
- 0685US8168410B2Anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2011·Granted May 1, 2012·4 cites·14 claims
- 0785US8101180B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofGOETSCH LILIANE·Filed 2009·Granted Jan 24, 2012·5 cites·12 claims
- 0885US7553485B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofPF MEDICAMENT·Filed 2004·Granted Jun 30, 2009·18 cites·5 claims
- 0984US11219693B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2019·Granted Jan 11, 2022·1 cites·26 claims
- 1082US10314921B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Jun 11, 2019·3 cites·23 claims
- 1176US8198413B2Anti-CD151 antibodies and their use in the treatment of cancerHAEUW JEAN-FRANCOIS·Filed 2009·Granted Jun 12, 2012·2 cites·24 claims
- 1272US11673931B2Immunocytokines for the treatment of cancerPF MEDICAMENT·Filed 2020·Granted Jun 13, 2023·1 cites·11 claims
- 1371US8178096B2Use of an anti-CD151 antibody in the treatment of cancerHAEUW JEAN-FRANCOIS·Filed 2007·Granted May 15, 2012·1 cites·11 claims
- 1469US2024350657A1Sulfomaleimide-based linkers and corresponding conjugatesPF MEDICAMENT·Filed 2024·Application pending·0 cites
- 1561US12011485B2Sulfomaleimide-based linkers and corresponding conjugatesPF MEDICAMENT·Filed 2019·Granted Jun 18, 2024·0 cites·18 claims
- 1659US11661457B2IGF-1R antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2020·Granted May 30, 2023·0 cites·23 claims
- 1757US2008063639A1Method for the treatment of psoriasis comprising novel anti-IGF-IR antibodiesPF MEDICAMENT·Filed 2007·Application pending·0 cites
- 1856US8808999B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofGOETSCH LILIANE·Filed 2012·Granted Aug 19, 2014·0 cites·12 claims
- 1956US2014193329A1Anti-cd151 antibodies and their use in the treatment of cancerFinnegan LLP·Filed 2013·Application pending·0 cites
- 2054US6780420B1Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccinePF MEDICAMENT·Filed 2000·Granted Aug 24, 2004·0 cites·11 claims
- 2151US2011165062A1Use of an anti-cd151 antibody for early treatment of cancerPF MEDICAMENT·Filed 2009·Application pending·0 cites
- 2250US8697855B2Anti-CD151 antibodies and their use in the treatment of cancerHAEUW JEAN-FRANÇOIS·Filed 2012·Granted Apr 15, 2014·0 cites·16 claims
- 2350US2012156191A1Anti-jam-a antibodiesGOETSCH LILIANE·Filed 2011·Application pending·0 cites
- 2449US2022048966A1New immunocytokines for the treatment of cancerPF MEDICAMENT·Filed 2019·Application pending·0 cites
- 2546US2012219569A1Use of an anti-cd151 antibody in the treatment of cancerHAEUW JEAN-FRANCOIS·Filed 2012·Application pending·0 cites
- 2639US2012171114A1Anti-cd151 antibodies and their use in the treatment of cancerHAEUW JEAN-FRANCOIS·Filed 2011·Application pending·0 cites
- 2739US2013303734A1Novel homogeneous humanized antiproliferation antibodiesGOETSCH LILIANE·Filed 2011·Application pending·0 cites
- 2839US2004014661A1Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvantFiled 2001·Application pending·0 cites
- 2937US6197929B1Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccinePF MEDICAMENT·Filed 1995·Granted Mar 6, 2001·3 cites·1 claims
- 3034US2012275997A1Chimeric antibodies specific for cd151 and use thereof in the treatment of cancerHAEUW JEAN-FRANCOIS·Filed 2010·Application pending·0 cites
- 3129US7408044B2Carrier protein having an adjuvant effectPF MEDICAMENT·Filed 2004·Granted Aug 5, 2008·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →